REVIEW PAPER
Differential diagnosis of idiopathic inflammatory myopathies in adults – the first step when approaching a patient with muscle weakness
Submission date: 2018-06-25
Final revision date: 2018-09-11
Acceptance date: 2018-09-26
Online publication date: 2018-10-31
Publication date: 2018-10-31
Reumatologia 2018;56(5):307-315
KEYWORDS
TOPICS
ABSTRACT
Despite its misleading adjective, the most commonly used diagnostic criteria of idiopathic inflammatory myopathies (IIM) are applicable only after all other non-autoimmune muscle diseases have been excluded. It makes differential diagnosis the first step when approaching a patient with muscle weakness. This article is designed to list the most common conditions from which to differentiate in rheumatological care. In fact, many patients with the diseases described here have been initially misdiagnosed with IIM. For the purpose of this article, only the most commonly found and important conditions according to the authors are listed with the essence of information; other autoimmune muscle diseases, such as sarcoidosis and eosinophilic myositis, are not portrayed. The attached bibliography may serve as a source, when further exploration of a specific subject is needed.
REFERENCES (56)
1.
Pasnoor M, Barohn RJ, Dimachkie MM. Toxic myopathies. Neurol Clin 2014; 32: 647-670.
2.
Silva M, Matthews ML, Jarvis C, et al. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy. Clin Ther 2007; 29: 253-260.
3.
Needham M, Fabian V, Knezevic W, et al. Progressive myopathy with up-regulation of MHCI associated with statin therapy. Neuromuscul Disord 2007; 17: 194-200.
4.
Mammen AL, Chung T, Christopher-Stine L, et al. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy. Arthritis Rheum 2011; 63: 713-721.
5.
Mohassel P, Mammen AL. The spectrum of statin myopathy. Curr Opin Rheumatol 2013; 25: 747-752.
6.
Grable-Esposito P, Katzberg HD, Greenberg SA, et al. Immune-mediated necrotizing myopathy associated with statins. Muscle Nerve 2010; 41: 185-190.
7.
Mammen AL. Necrotizing myopathies: beyond statins. Curr Opin Rheumatol 2014; 26: 679-683.
8.
Preedy VR, Ohlendieck K, Adachi J, et al. The importance of alcohol-induced muscle disease. J Muscle Res Cell Motil 2003; 24: 55-63.
9.
Khaleeli AA, Edwards RH, Gohil K, et al. Corticosteroid myopathy: a clinical and pathological study. Clin Endocrinol 1983; 18: 155-166.
10.
Hanson P, Dive A, Brucher JM, et al. Acute corticosteroid myopathy in intensive care patients. Muscle Nerve 1997; 20: 1371-1380.
11.
Faludi G, Gotlieb J, Meyers J. Factors influencing the development of steroid-induced myopathies. Ann N Y Acad Sci 1966; 138: 62-72.
12.
Lacomis D, Giuliani MJ, Van Cott A, Kramer DJ. Acute myopathy of intensive care: clinical, electromyographic, and pathological aspects. Ann Neurol 1996; 40: 645-654.
13.
Wood-Allum CA, Shaw PJ. Thyroid disease and the nervous system. Handb Clin Neurol 2014; 120: 703-735.
14.
Duyff RF, Van den Bosch JV, Laman DM, et al. Neuromuscular findings in thyroid dysfunction: a prospective clinical and electrodiagnostic study. J Neurol Neurosurg Psychiatry 2000; 68: 750-755.
15.
Rodolico C, Toscano A, Benvenga S, Vita G. Skeletal muscle disturbances may precede clinical and laboratory evidence of autoimmune hypothyroidism. J Neurol 1998; 245: 555-556.
16.
McDaniel HG, Pittman CS, Oh SJ, Di Mauro S. Carbohydrate metabolism in hypothyroid myopathy. Metabolism 1977; 26: 867-873.
17.
Amato AA. Endocrine myopathies and toxic myopathies. In: Neuromuscular Function and Disease: Basic, Clinical, and Electrodiagnostic Aspects, Brown WF, Bolton CF, Aminoff MJ (eds.), vol. 2. W.B. Saunders, Philadelphia 2002: 1399-1402.
18.
Celsing F, Blomstrand E, Melichna J, et al. Effect of hyperthyroidism on fibre area, glycogen content, and enzyme activity in human skeletal muscle. Clin Physiol 1986; 6: 171-181.
19.
Iyer SN, Drake AJ III, West RL, et al. Diabetic muscle infarction: a rare complication of long-standing and poorly controlled diabetes mellitus. Case Rep Med 2011; 2011: 407921.
20.
Barohn RJ, Kissel JT. Case of the month: painful thigh mass in a young woman: diabetic muscle infarction. Muscle Nerve 1992; 15: 850-855.
21.
Pastorello E, Cao M, Trevisan CP. Atypical onset in a series of122 cases with facioscapulohumeral muscular dystrophy. Clin Neurol Neurosurg 2012; 114: 230-234.
22.
Paradas C, González-Quereda L, De Luna N, et al. A new phenotype of dysferlinopathy with congenital onset. Neuromuscul Disord 2009; 19: 21-25.
24.
a mutation with late onset of limb girdle muscular dystrophy 2B. J Neurol Neurosurg Psychiatry 2013; 84: 433-440.
25.
Degardin A, Morillon D, Lacour A, et al. Morphologic imaging in muscular dystrophies and inflammatory myopathies. Skeletal Radiol 2010; 39: 1219-1227.
26.
Cotta A, Carvalho E, da-Cunha-Júnior AL, et al. Common recessive limb girdle muscular dystrophies differential diagnosis: why and how? Arq Neuro-Psiquiatr 2014; 72: 721-734.
27.
Tidball JG, Wehling-Henricks M. Damage and inflammation in muscular dystrophy: potential implications and relationships with autoimmune myositis. Curr Opin Rheumatol 2005; 17: 707-713.
28.
O’Suilleabhain P, Low PA, Lennon VA. Autonomic dysfunction in the Lambert-Eaton myasthenic syndrome: serologic and clinical correlates. Neurology 1998; 50: 88.
29.
Schüller A, Wenninger S, Strigl-Pill N, Schoser B. Toward deconstructing the phenotype of late-onset Pompe disease. Am.
31.
Cupler EJ, Berger KI, Leshner RT, et al.; AANEM Consensus Committee on Late-onset Pompe Disease. Consensus treatment recommendations for late-onset Pompe disease. Muscle Nerve 2012; 45: 319-333.
32.
Lucia A, Quinlivan R, Wakelin A, et al. The ‘McArdle paradox’: exercise is a good advice for the exercise intolerant. Br J Sports Med 2013; 47: 728-729.
33.
Fischer J, Lefevre C, Morava E, et al. The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy. Nat Genet 2007; 39: 28-30.
34.
Liang WC, Nishino I. Lipid storage myopathy. Curr Neurol Neurosci Rep 2012; 11: 97-103.
35.
Ørngreen MC, Ejstrup R, Vissing J. Effect of diet on exercise tolerance in carnitine palmitoyltransferase II deficiency. Neurology 2003; 61: 559-561.
36.
Crum-Cianflone NF. Bacterial, fungal, parasitic, and viral myositis. Clin Microbiol Rev 2008; 21: 473-494.
37.
Tabbutt S, Leonard M, Godinez RI, et al. Severe influenza B myocarditis and myositis. Pediatr Crit Care Med 2004; 5: 403-406.
38.
Davis LE, Kornfeld M. Experimental influenza B viral myositis. J Neurol Sci 2001; 187: 61-67.
39.
Fodili F, van Bommel EF. Severe rhabdomyolysis and acute renal failure following recent Coxsackie B virus infection. Neth J Med 2003; 61: 177-179.
40.
Jehn UW, Fink MK. Myositis, myoglobinemia, and myoglobinuria associated with enterovirus echo 9 infection. Arch Neurol 1980; 37: 457- 458.
41.
Sakata H, Taketazu G, Nagaya K, et al. Outbreak of severe infection due to adenovirus type 7 in a paediatric ward in Japan. J Hosp Infect 1998; 39: 207-211.
42.
Naylor CD, Jevnikar AM, Witt NJ. Sporadic viral myositis in two adults. CMAJ 1987; 137: 819-821.
43.
Johnson RW, Williams FM, Kazi S, et al. Human immunodeficiency virus-associated polymyositis: a longitudinal study of outcome. Arthritis Rheum 2003; 49: 172-178.
44.
Wright RA, Plant GT, Landon DN, et al. Nemaline myopathy: an unusual cause of ophthalmoparesis. J Neuroophthalmol 1997; 17: 39-43.
45.
Morgan OS, Rodgers-Johnson P, Mora C, Char G. HTLV-1 and polymyositis in Jamaica. Lancet 1989; 2: 1184-1187.
46.
Nojima T, Hirakata M, Sato S, et al. 2000. A case of polymyositis associated with hepatitis B infection. Clin Exp Rheumatol 2000; 18: 86-88.
47.
Maeda M, Maeda A, Wakiguchi H, et al. Polymyositis associated with primary cytomegalovirus infection. Scand J Infect Dis 2000; 32: 212-214.
48.
Uchiyama T, Arai K, Yamamoto-Tabata T, et al. Generalized myositis mimicking polymyositis associated with chronic active Epstein-Barr virus infection. J Neurol 2005; 252: 519-525.
49.
Schlesinger JJ, Gandara D, Bensch KG. Myoglobinuria associated with herpes-group viral infections. Arch Intern Med 1978; 138: 422-424.
50.
Badilla J, Dolman PJ. Orbital myositis involving the oblique muscles associated with herpes zoster ophthalmicus. Ophthal Plast Reconstr Surg 2007; 23: 411-413.
51.
Finsterer J, Kongchan K. Severe, persisting, steroid-responsive Dengue myositis. J Clin Virol 2006; 35: 426-428.
52.
Jeandel C, Perret C, Blain H, et al. Rhabdomyolysis with acute renal failure due to Borrelia burgdorferi [letter]. J Int Med 1994; 235: 191-192.
53.
Jarowski CI, Fialk MA, Murray HW, et al. Fever, rash, and muscle tenderness. Adistinctive clinical presentation of disseminated candidiasis. Arch Intern Med 1978; 138: 544-546.
54.
Diggs CH, Eskenasy GM, Sutherland JC, Wiernik PH. Fungal infection of muscle in acute leukemia. Cancer 1976; 38: 1771-1772.
55.
Grunau BE, Pourvali R, Wiens MO, et al. Characteristics and thirty-day outcomes of emergency department patients with elevated creatine kinase. Acad Emerg Med 2014; 21: 631-636.
56.
Leverenz D, Zaha O, Crofford LJ, Chung CP. Causes of creatine kinase levels greater than 1000 IU/L in patients referred to rheumatology. Clin Rheumatol 2016; 35: 1541-1547.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Share
RELATED ARTICLE
| eISSN: | 2084-9834 |
| ISSN: | 0034-6233 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
